Blood biomarkers in chronic airways diseases and their role in diagnosis and management

References

• Gauthier M, Ray A, Wenzel SE. Evolving concepts of asthma. Am J Respir Crit Care Med. 2015 Sep 15;192(6):660–668. PubMed PMID: 26161792; PubMed Central PMCID: PMCPMC5447293.
   PubMed Web of Science ®Google Scholar
• Agusti A. The path to personalised medicine in COPD. Thorax. 2014 Sep;69(9):857–864. PubMed PMID: 24781218.
   PubMed Web of Science ®Google Scholar
• Shrimanker R, Choo XN, Pavord ID. A new approach to the classification and management of airways diseases: identification of treatable traits. Clin Sci (Lond). 2017 May 01;131(10):1027–1043. PubMed PMID: 28487412.
   PubMed Web of Science ®Google Scholar
• Bel EH, Ten Brinke A. New anti-eosinophil drugs for asthma and COPD: targeting the trait! Chest. 2017 Jun 02. PubMed PMID: 28583618; eng. DOI:10.1016/j.chest.2017.05.019
   PubMed Web of Science ®Google Scholar
• Vijverberg SJ, Hilvering B, Raaijmakers JA, et al. Clinical utility of asthma biomarkers: from bench to bedside. Biologics. 2013;7:199–210. PubMed PMID: 24009412; PubMed Central PMCID: PMCPMC3762671.
   PubMedGoogle Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention 2017. Available from: www.ginasthma.org. Accessed on: 18 Jan 2018.
   Google Scholar
• Fahy JV. Type 2 inflammation in asthma–present in most, absent in many. Nat Rev Immunol. 2015 Jan;15(1):57–65. PubMed PMID: 25534623; PubMed Central PMCID: PMCPMC4390063.
   PubMed Web of Science ®Google Scholar
• Postma DS, Rabe KF. The asthma-COPD overlap syndrome. N Engl J Med. 2015 Sep 24;373(13):1241–1249. PubMed PMID: 26398072.
   PubMed Web of Science ®Google Scholar
• Israel E, Reddel HK. Severe and difficult-to-treat asthma in adults. N Engl J Med. 2017 Sep 07;377(10):965–976. PubMed PMID: 28877019.
   PubMed Web of Science ®Google Scholar
• Olin JT, Wechsler ME. Asthma: pathogenesis and novel drugs for treatment. Bmj. 2014 Nov 24;349:g5517.
   PubMed Web of Science ®Google Scholar
• Peters MC, McGrath KW, Hawkins GA, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016;4(7):574–584.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for fhe diagnosis, management, and prevention of chronic obstructive pulmonary disease 2017. Available from: www.goldcopd.org. Accessed on 18 Jan 2018.
   Google Scholar
• Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008 Mar;8(3):183–192. PubMed PMID: 18274560.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016 Jul;138(1):16–27. PubMed PMID: 27373322.
   PubMed Web of Science ®Google Scholar
• Dean K, Niven R. Asthma phenotypes and endotypes: implications for personalised therapy. BioDrugs. 2017 Sep 06. PubMed PMID: 28879503. DOI:10.1007/s40259-017-0242-5
   PubMed Web of Science ®Google Scholar
• Bossley CJ, Fleming L, Gupta A, et al. Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol. 2012 Apr;129(4):974–82 e13. PubMed PMID: 22385633; PubMed Central PMCID: PMCPMC3381727.
   PubMed Web of Science ®Google Scholar
• Uhm TG, Kim BS, Chung IY. Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma. Allergy Asthma Immunol Res. 2012 Mar;4(2):68–79. PubMed PMID: 22379601; PubMed Central PMCID: PMCPMC3283796.
   PubMed Web of Science ®Google Scholar
• De Monchy JGR, Kauffman HF, Venge P, et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis. 1985;131:373–376.
   PubMed Web of Science ®Google Scholar
• Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999 Sep;160(3):1001–1008. PubMed PMID: 10471631.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Sterk PJ, Hargreave FE, et al. Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J. 2002;20(Supplement 37):40S–43s.
   Google Scholar
• Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. The Lancet. 2002;360(9347):1715–1721.
   PubMed Web of Science ®Google Scholar
• Petsky HL, Cates CJ, Lasserson TJ, et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax. 2012 Mar;67(3):199–208. PubMed PMID: 20937641.
   PubMed Web of Science ®Google Scholar
• Ortega HG, Yancey SW, Mayer B, et al. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies. Lancet Respir Med. 2016;4(7):549–556.
   PubMed Web of Science ®Google Scholar
• Price DB, Rigazio A, Campbell JD, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015 Nov;3(11):849–858. PubMed PMID: 26493938.
   PubMed Web of Science ®Google Scholar
• Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016 Feb;47(2):410–419. PubMed PMID: 26828055.
   PubMed Web of Science ®Google Scholar
• Wagener AH, De Nijs SB, Lutter R, et al. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax. 2015 Feb;70(2):115–120. PubMed PMID: 25422384.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Simpson JL, Powell H, et al. Full blood count parameters for the detection of asthma inflammatory phenotypes. Clin Exp Allergy. 2014 Sep;44(9):1137–1145. PubMed PMID: 24849076.
   PubMed Web of Science ®Google Scholar
• Ortega H, Katz L, Gunsoy N, et al. Blood eosinophil counts predict treatment response in patients with severe eosinophilic asthma. J Allergy Clin Immunol. 2015 09 01;136(3):825–826.
   PubMed Web of Science ®Google Scholar
• Korevaar DA, Westerhof GA, Wang J, et al. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(4):290–300.
   PubMed Web of Science ®Google Scholar
• Westerhof GA, Korevaar DA, Amelink M, et al. Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes. Eur Respir J. 2015 Sep;46(3):688–696. PubMed PMID: 26113672.
   PubMed Web of Science ®Google Scholar
• Negewo NA, McDonald VM, Baines KJ, et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1495–1504. PubMed PMID: 27445469; PubMed Central PMCID: PMCPMC4936821.
   PubMed Web of Science ®Google Scholar
• Hastie AT, Martinez FJ, Curtis JL, et al. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017. DOI:10.1016/s2213-2600(17)30432-0.
   PubMed Web of Science ®Google Scholar
• Vedel-Krogh S, Nielsen SF, Lange P, et al. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The copenhagen general population study. Am J Respir Crit Care Med. 2016 May 01;193(9):965–974. PubMed PMID: 26641631.
   PubMed Web of Science ®Google Scholar
• Bafadhel M. Eosinophils in COPD: are we nearly there yet? Lancet Respir Med. 2017 Nov 13. PubMed PMID: 29146300. DOI:10.1016/S2213-2600(17)30445-9
   Web of Science ®Google Scholar
• Kerkhof M, Sonnappa S, Postma DS, et al. Blood eosinophil count and exacerbation risk in patients with COPD. Eur Respir J. 2017 Jul;50(1). PubMed PMID: 28729477. DOI:10.1183/13993003.00761-2017.
   Web of Science ®Google Scholar
• Hastie AT, Moore WC, Li H, et al. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol. 2013 Jul;132(1):72–80. PubMed PMID: 23706399; PubMed Central PMCID: PMCPMC3704048.
   PubMed Web of Science ®Google Scholar
• Griffin E, Hakansson L, Formgren H, et al. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol. 1991;87(2):548–557.
   PubMed Web of Science ®Google Scholar
• Johansson MW. Activation states of blood eosinophils in asthma. Clin Exp Allergy. 2014 Apr;44(4):482–498. PubMed PMID: 24552191; PubMed Central PMCID: PMCPMC4057046.
   PubMed Web of Science ®Google Scholar
• Johansson MW. Eosinophil activation status in separate compartments and association with asthma. Front Med (Lausanne). 2017;4:75. PubMed PMID: 28660189; PubMed Central PMCID: PMCPMC5466952.
   PubMed Web of Science ®Google Scholar
• Hilvering B, Vijverberg SJH, Jansen J, et al. Diagnosing eosinophilic asthma using a multivariate prediction model based on blood granulocyte responsiveness. Allergy. 2017 Aug;72(8):1202–1211. PubMed PMID: 28029172.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012 Jul 1;186(1):48–55. PubMed PMID: 22447964; PubMed Central PMCID: PMCPMC3400995.
   PubMed Web of Science ®Google Scholar
• Sivapalan P, Moberg M, Eklof J, et al. A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol. BMC Pulm Med. 2017 Aug 15;17(1):114. PubMed PMID: 28810909; PubMed Central PMCID: PMCPMC5558695.
   PubMedGoogle Scholar
• Mathioudakis AG, Chatzimavridou-Grigoriadou V, Corlateanu A, et al. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis. Eur Respir Rev. 2017 Jan;26(143). PubMed PMID: 28143877. DOI:10.1183/16000617.0073-2016.
   PubMed Web of Science ®Google Scholar
• Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009 Mar 05;360(10):973–984. PubMed PMID: 19264686; PubMed Central PMCID: PMCPMC3992367.
   PubMed Web of Science ®Google Scholar
• Bel EH, Wenzel SE, Thompson PJ, et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med. 2014 Sep 25;371(13):1189–1197. PubMed PMID: 25199060.
   PubMed Web of Science ®Google Scholar
• Castro M, Zangrilli J, Wechsler ME, et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med. 2015;3(5):355–366.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Korn S, Bleecker ER, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012 August 18;380:651–659.
   PubMed Web of Science ®Google Scholar
• Brightling CE, Bleecker ER, Panettieri RA, et al. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med. 2014;2(11):891–901.
   PubMed Web of Science ®Google Scholar
• Pascoe S, Locantore N, Dransfield MT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3(6):435–442.
   PubMed Web of Science ®Google Scholar
• Siddiqui SH, Guasconi A, Vestbo J, et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015 Aug 15;192(4):523–525. PubMed PMID: 26051430; PubMed Central PMCID: PMCPMC4595668.
   PubMed Web of Science ®Google Scholar
• Cheng SL, Lin CH. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts. Int J Chron Obstruct Pulmon Dis. 2016;11:2341–2348. PubMed PMID: 27703344; PubMed Central PMCID: PMCPMC5036601.
   PubMed Web of Science ®Google Scholar
• Iqbal A, Barnes NC, Brooks J. Is blood eosinophil count a predictor of response to bronchodilators in chronic obstructive pulmonary disease? Results from post hoc subgroup analyses. Clin Drug Investig. 2015 Oct;35(10):685–688. PubMed PMID: 26329916; PubMed Central PMCID: PMCPMC4579251.
   PubMed Web of Science ®Google Scholar
• Watz H, Tetzlaff K, Wouters EFM, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med. 2016;4(5):390–398.
   PubMed Web of Science ®Google Scholar
• Papi A, Kostikas K, Wedzicha JA, et al. Dual bronchodilation response by exacerbation history and eosinophilia in the FLAME study. Am J Respir Crit Care Med. 2017 forthcoming. PubMed Central PMCID: PMC29099609. DOI:10.1164/rccm.201709-1822LE
   PubMedGoogle Scholar
• Koh GC, Shek LP, Goh DY, et al. Eosinophil cationic protein: is it useful in asthma? A systematic review. Respir Med. 2007 Apr;101(4):696–705. PubMed PMID: 17034998.
   PubMed Web of Science ®Google Scholar
• Peona V, De Amici M, Quaglini S, et al. Serum eosinophilic cationic protein: is there a role in respiratory disorders? J Asthma. 2010 Mar;47(2):131–134. PubMed PMID: 20170318.
   PubMed Web of Science ®Google Scholar
• Jiang XG, Yang XD, Lv Z, et al. Elevated serum levels of TNF-alpha, IL-8, and ECP can be involved in the development and progression of bronchial asthma. J Asthma. 2017 Apr 11:1–8. PubMed PMID: 28399677. DOI: 10.1080/02770903.2017.1318141
   PubMed Web of Science ®Google Scholar
• Gorska K, Paplinska-Goryca M, Nejman-Gryz P, et al. Eosinophilic and neutrophilic airway inflammation in the phenotyping of mild-to-moderate asthma and chronic obstructive pulmonary disease. Copd. 2017 Apr;14(2):181–189. PubMed PMID: 27983888.
   PubMedGoogle Scholar
• Venge P, Byström J, Carlson M, et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy. 1999;29:1172–1186.
   PubMed Web of Science ®Google Scholar
• Al Obaidi A, Al Samarai A, Al-Janabi J, et al. The predictive value of eosinophil cationic protein and lactate dehydrogenase in asthma: a comparative study of serum versus sputum. WAO Journal. 2009;2:144–149.
   Google Scholar
• Mogensen I, Alving K, Bjerg A, et al. Simultaneously elevated exhaled nitric oxide and serum-eosinophil cationic protein relate to recent asthma events in asthmatics in a cross-sectional population-based study. Clin Exp Allergy. 2016 Dec;46(12):1540–1548. PubMed PMID: 27513280.
   PubMed Web of Science ®Google Scholar
• Yang QF, Lu TT, Shu CM, et al. Eosinophilic biomarkers for detection of acute exacerbation of chronic obstructive pulmonary disease with or without pulmonary embolism. Exp Ther Med. 2017 Oct;14(4):3198–3206. PubMed PMID: 28912870; PubMed Central PMCID: PMCPMC5585757.
   PubMed Web of Science ®Google Scholar
• Meijer RJ, Postma DS, Kauffman HF, et al. Accuracy of eosinophils and eosinophilic cationic protein to predict steroid improvement in asthma. Clin Exp Allergy. 2002;32:1096–1103.
   PubMed Web of Science ®Google Scholar
• Doran E, Cai F, Holweg CTJ, et al. Interleukin-13 in asthma and other eosinophilic disorders. Front Med (Lausanne). 2017;4:139. PubMed PMID: 29034234; PubMed Central PMCID: PMCPMC5627038.
   PubMed Web of Science ®Google Scholar
• Anderson WC 3rd, Apter AJ, Dutmer CM, et al. Advances in asthma in 2016: designing individualized approaches to management. J Allergy Clin Immunol. 2017 Sep;140(3):671–680. PubMed PMID: 28709967.
   PubMed Web of Science ®Google Scholar
• Skevaki C, Van Den Berg J, Jones N, et al. Immune biomarkers in the spectrum of childhood noncommunicable diseases. J Allergy Clin Immunol. 2016 May;137(5):1302–1316. PubMed PMID: 27155027.
   PubMed Web of Science ®Google Scholar
• Li W, Gao P, Zhi Y, et al. Periostin: its role in asthma and its potential as a diagnostic or therapeutic target. Respir Res. 2015 May 17;16:57. PubMed PMID: 25981515; PubMed Central PMCID: PMCPMC4437675.
   PubMed Web of Science ®Google Scholar
• Fingleton J, Braithwaite I, Travers J, et al. Serum periostin in obstructive airways disease. Eur Respir J. 2016 May;47(5):1383–1391. PubMed PMID: 26917610; PubMed Central PMCID: PMCPMC4851937.
   PubMed Web of Science ®Google Scholar
• Simpson JL, Yang IA, Upham JW, et al. Periostin levels and eosinophilic inflammation in poorly-controlled asthma. BMC Pulm Med. 2016 Apr 30;16(1):67. PubMed PMID: 27130294; PubMed Central PMCID: PMCPMC4851782.
   PubMed Web of Science ®Google Scholar
• Gorska K, Maskey-Warzechowska M, Nejman-Gryz P, et al. Comparative study of periostin expression in different respiratory samples in patients with asthma and chronic obstructive pulmonary disease. Pol Arch Med Wewn. 2016;126(3):124–137. PubMed PMID: 26895432.
   PubMed Web of Science ®Google Scholar
• Han SS, Lee WH, Hong Y, et al. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease. J Asthma. 2016 Aug;53(6):583–588. PubMed PMID: 27104648.
   PubMed Web of Science ®Google Scholar
• Katoh S, Ikeda M, Shirai R, et al. Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease. J Asthma. 2017 Oct 16. PubMed PMID: 29035604. DOI: 10.1080/02770903.2017.1391281
   PubMed Web of Science ®Google Scholar
• Johansson MW, Evans MD, Crisafi GM, et al. Serum periostin is associated with type 2 immunity in severe asthma. J Allergy Clin Immunol. 2016 Jun;137(6):1904–1907 e2. PubMed PMID: 27061252; PubMed Central PMCID: PMCPMC5580680.
   PubMed Web of Science ®Google Scholar
• Hanania NA, Noonan M, Corren J, et al. Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax. 2015 Aug;70(8):748–756. PubMed PMID: 26001563; PubMed Central PMCID: PMCPMC4515999.
   PubMed Web of Science ®Google Scholar
• Brightling CE, Chanez P, Leigh R, et al. Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med. 2015;3(9):692–701.
   PubMed Web of Science ®Google Scholar
• Harris JM, Maciuca R, Bradley MS, et al. A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma. Respir Res. 2016 Mar 18;17:29. PubMed PMID: 26993628; PubMed Central PMCID: PMCPMC4797126.
   PubMed Web of Science ®Google Scholar
• Park HY, Lee H, Koh WJ, et al. Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients. Int J Chron Obstruct Pulmon Dis. 2016;11:23–30. PubMed PMID: 26730185; PubMed Central PMCID: PMCPMC4694663.
   PubMed Web of Science ®Google Scholar
• Hanania NA, Wenzel S, Rosen K, et al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013 Apr 15;187(8):804–811. PubMed PMID: 23471469.
   PubMed Web of Science ®Google Scholar
• Froidure A, Mouthuy J, Durham SR, et al. Asthma phenotypes and IgE responses. Eur Respir J. 2016 Jan;47(1):304–319. PubMed PMID: 26677936.
   PubMed Web of Science ®Google Scholar
• Dullaers M, De Bruyne R, Ramadani F, et al. The who, where, and when of IgE in allergic airway disease. J Allergy Clin Immunol. 2012 Mar;129(3):635–645. PubMed PMID: 22168998.
   PubMed Web of Science ®Google Scholar
• Ahmad Al Obaidi AH, Mohamed Al Samarai AG, Yahya Al Samarai AK, et al. The predictive value of IgE as biomarker in asthma. J Asthma. 2008 Oct;45(8):654–663. PubMed PMID: 18951256.
   PubMed Web of Science ®Google Scholar
• Djukanovic R, Wilson SJ, Kraft M, et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med. 2004 Sep 15;170(6):583–593. PubMed PMID: 15172898.
   PubMed Web of Science ®Google Scholar
• Simpson A, Soderstrom L, Ahlstedt S, et al. IgE antibody quantification and the probability of wheeze in preschool children. J Allergy Clin Immunol. 2005 Oct;116(4):744–749. PubMed PMID: 16210045.
   PubMed Web of Science ®Google Scholar
• Rajendra C, Zoratti E, Havstad S, et al. Relationships between total and allergen-specific serum IgE concentrations and lung function in young adults. Ann Allergy Asthma Immunol. 2012 Jun;108(6):429–434. PubMed PMID: 22626596; PubMed Central PMCID: PMCPMC3956048.
   PubMed Web of Science ®Google Scholar
• Sherrill DL, Lebowitz MD, Halonen M, et al. Longitudinal evaluation of the association between pulmonary function and total serum IgE. Am J Respir Crit Care Med. 1995;152(1):98–102. PubMed Central PMCID: PMC7599870.
   PubMed Web of Science ®Google Scholar
• Tanaka A, Jinno M, Hirai K, et al. Longitudinal increase in total IgE levels in patients with adult asthma: an association with poor asthma control. Respir Res. 2014;15(144):1-8.
   PubMedGoogle Scholar
• Pelaia G, Gallelli L, Renda T, et al. Update on optimal use of omalizumab in management of asthma. J Asthma Allergy. 2011;4:49–59. PubMed PMID: 21792319; PubMed Central PMCID: PMCPMC3140296.
   PubMedGoogle Scholar
• Bousquet J, Wenzel S, Holgate S, et al. Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma. Chest. 2004;125:1378–1386.
   PubMed Web of Science ®Google Scholar
• Normansell R, Walker S, Milan SJ, et al. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014 Jan 13;1:CD003559. PubMed PMID: 24414989.
   PubMed Web of Science ®Google Scholar
• Duvoix A, Dickens J, Haq I, et al. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax. 2013 Jul;68(7):670–676. PubMed PMID: 22744884; PubMed Central PMCID: PMCPMC3711372.
   PubMed Web of Science ®Google Scholar
• Merrill DD, Rennard SI, Tal-Singer R. New biomarkers: why are they critical to the future of COPD research? How the COPD biomarker qualification consortium (CBQC) work will deliver results. Lung Health Professional Magazine. 2013;4(3):30–36.
   Google Scholar
• Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the third national health and nutrition examination. Am J Med. 2003;114(9):758–762.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Tal-Singer R, Lomas DA, et al. Plasma fibrinogen as a biomarker for mortality and hospitalized exacerbations in people with COPD. Chronic Obstr Pulm Dis. 2015;2(1):23–34. PubMed PMID: 25685850; PubMed Central PMCID: PMCPMC4326107.
   PubMed Web of Science ®Google Scholar
• Faner R, Agusti A. Fibrinogen and COPD: now what? J Copd F. 2015;2(1):1–3.
   PubMedGoogle Scholar
• Demarche S, Schleich F, Henket M, et al. Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory? BMC Pulm Med. 2016 Apr 5;16:46. PubMed PMID: 27044366; PubMed Central PMCID: PMCPMC4820945.
   PubMed Web of Science ®Google Scholar
• Wood LG, Baines KJ, Fu J, et al. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest. 2012 Jul;142(1):86–93. PubMed PMID: 22345378.
   PubMed Web of Science ®Google Scholar
• Agache I, Ciobanu C, Agache C, et al. Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med. 2010 Aug;104(8):1131–1137. PubMed PMID: 20338742.
   PubMed Web of Science ®Google Scholar
• Rufo J, Taborda-Barata L, Lourenco O. Serum biomarkers in elderly asthma. J Asthma. 2013 Dec;50(10):1011–1019. PubMed PMID: 23952480.
   PubMed Web of Science ®Google Scholar
• Bradford E, Jacobson S, Varasteh J, et al. The value of blood cytokines and chemokines in assessing COPD. Respir Res. 2017 Oct 24;18(1):180. PubMed PMID: 29065892; PubMed Central PMCID: PMCPMC5655820.
   PubMedGoogle Scholar
• Kato M, Suzuki K, Yamada Y, et al. Virus detection and cytokine profile in relation to age among acute exacerbations of childhood asthma. Allergol Int. 2015 Sep;64(Suppl):S64–S70. PubMed PMID: 26344082.
   PubMedGoogle Scholar
• Patil SP, Wisnivesky JP, Busse PJ, et al. Detection of immunological biomarkers correlated with asthma control and quality of life measurements in sera from chronic asthmatic patients. Ann Allergy Asthma Immunol. 2011 Mar;106(3):205–213. PubMed PMID: 21354022; PubMed Central PMCID: PMCPMC4648242.
   PubMed Web of Science ®Google Scholar
• Kuang Z, Wilson JJ, Luo S, et al. Deciphering asthma biomarkers with protein profiling technology. Int J Inflam. 2015;2015:630637. PubMed PMID: 26346739; PubMed Central PMCID: PMCPMC4543788.
   PubMedGoogle Scholar
• Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009 Aug;64(8):728–735. PubMed PMID: 19638566.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining airways diseases. The Lancet. 2017. DOI:10.1016/s0140-6736(17)30879-6.
   Web of Science ®Google Scholar
• Nagasaki T, Matsumoto H, Kanemitsu Y, et al. Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma. Am J Respir Crit Care Med. 2014;190(12):1449–1452.
   Google Scholar
• Medrek SK, Parulekar AD, Hanania NA. Predictive biomarkers for asthma therapy. Curr Allergy Asthma Rep. 2017 Sep 19;17(10):69. PubMed PMID: 28929293.
   PubMed Web of Science ®Google Scholar
• Belgrave D, Henderson J, Simpson A, et al. Disaggregating asthma: big investigation versus big data. J Allergy Clin Immunol. 2017 Feb;139(2):400–407. PubMed PMID: 27871876; PubMed Central PMCID: PMCPMC5292995.
   PubMed Web of Science ®Google Scholar
• MacIntyre EA, Carlsten C, MacNutt M, et al. Traffic, asthma and genetics: combining international birth cohort data to examine genetics as a mediator of traffic-related air pollution’s impact on childhood. Eur J Epidemiol. 2013;28:597–606.
   PubMed Web of Science ®Google Scholar
• Ghosh N, Dutta M, Singh B, et al. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update. Expert Rev Mol Diagn. 2016 Aug;16(8):897–913. PubMed PMID: 27267972.
   PubMed Web of Science ®Google Scholar
• Kan M, Shumyatcher M, Himes BE. Using omics approaches to understand pulmonary diseases. Respir Res. 2017 Aug 3;18(1):149. PubMed PMID: 28774304; PubMed Central PMCID: PMCPMC5543452.
   PubMedGoogle Scholar
• Wheelock CE, Goss VM, Balgoma D, et al. Application of ‘omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J. 2013 Sep;42(3):802–825. PubMed PMID: 23397306.
   PubMed Web of Science ®Google Scholar
• Lefaudeux D, De Meulder B, Loza MJ, et al. U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics. J Allergy Clin Immunol. 2017 Jun;139(6):1797–1807. PubMed PMID: 27773852.
   PubMed Web of Science ®Google Scholar
• Kuo CS, Pavlidis S, Loza M, et al. T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Eur Respir J. 2017 Feb;49(2). PubMed PMID: 28179442.
   Web of Science ®Google Scholar
• Neerincx AH, Vijverberg SJH, Bos LDJ, et al. Breathomics from exhaled volatile organic compounds in pediatric asthma. Pediatr Pulmonol. 2017 Dec;52(12):1616–1627. PubMed PMID: 29082668.
   PubMed Web of Science ®Google Scholar
• De Vries R, Dagelet YWF, Spoor P, et al. Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label. Eur Respir J. 2018 Jan;51 Pubmed PMID: 29326334.
   Web of Science ®Google Scholar
• Heffler E, Terranova G, Chessari C, et al. Point-of-care blood eosinophil count in a severe asthma clinic setting. Ann Allergy Asthma Immunol. 2017 Jul;119(1):16–20. PubMed PMID: 28668237.
   PubMed Web of Science ®Google Scholar
• Swaminathan S, Qirko K, Smith T, et al. A machine learning approach to triaging patients with chronic obstructive pulmonary disease. PLoS One. 2017;12(11):e0188532. PubMed PMID: 29166411; PubMed Central PMCID: PMCPMC5699810.
   PubMed Web of Science ®Google Scholar